Ann: Voluntary Suspension Extension, page-78

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 78 Last

Share
Profile

Follow
TheSanDiegoKid

724 Posts.

356

08/06/22

12:45

Post #: 61891939
Share

Originally posted by rustys33: ↑

I think there is too large a gap between what the owners of RAP are prepared to part ways for and what Pfizer are currently willing to pay.....this is the nature of blue sky investing meeting conservative corporate culture. If you were a Pfizer employee, you don't want to stake your career on something that my fail, as the upside doesn't offset the downside. Us investors stake our cash, but their is no reputational risk for backing a donkey.

That said, Pfizer want Covid diagnosis ASAP. A takeover would've been the fastest and simplest way to accomplish this both from a resourcing and approval perspective. RAP/Pfizer now return to the drawing board and need to come up with a plan to bring covid diagnosis to market ASAP. My guess is that the takeover bid is off the table and an extended product licensing agreement to get the product to market will be announced. These next steps, milestones and costings are what are being determined as we wait.

This explains;

- Phone calls assessing how much it would cost to acquire RAP
- Continued presentations by RAP at investor forums
- $4 million up front payment to continue covid diagnosis
- Length on trading suspension

Expand

The perfect scenario imh! Your bang on about the gap. They would be silly to offer much more when it's still yet to be commercialised, and we'd be silly to part ways at this price. Only way forward that benifits both parties is a partnership deal and really see what this baby can do.

Last edited by TheSanDiegoKid: 08/06/22

RAP Price at posting: 11.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

CBA breaks trading record on strong day for Aussie financials

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

There are more pages in this discussion • 11 more messages in this thread...

First 78 Last

Add RAP (ASX) to my watchlist

Ann: Voluntary Suspension Extension, page-78

Top Stories

CBA breaks trading record on strong day for Aussie financials

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Shekel Brainweigh investor presentation webinar – the future of retail automation

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Featured News